Recruiting NA Stroke

New treatment option for Stroke

Official title A Pilot Return-to-Work Cognitive Intervention After Stroke

ClinicalTrials.gov ID: NCT07116187

What this study is testing

What it's testing
This study addresses the growing burden of stroke in Singapore and highlights the lack of rehabilitation services for return to work after stroke. Despite functional physical recovery, many stroke survivors experience persistent impairments that hinder return-to-work.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 65

You may be able to join if

  • (for stroke survivors):
  • Between 21 to 65 years old
  • Ability to provide informed consent
  • Consent to recording / photo-taking
  • Living in the community with at least three months after stroke

You likely can't join if

  • (for stroke survivors):
  • Less than 21 years old
  • More than 65 years old
  • Unable to provide informed consent
  • Refuse recording
  • Not living in the community and having less than three months after stroke
See the full eligibility criteria
Who can join
  • (for stroke survivors):
  • Between 21 to 65 years old
  • Ability to provide informed consent
  • Consent to recording / photo-taking
  • Living in the community with at least three months after stroke
  • Looking to return to work or switch jobs after stroke
  • No significant aphasia or physical disability issues which will impede them from performing cognitive tasks in the interventions and assessments
  • No major psychiatric illnesses
  • Able to understand and converse in English
  • Score on MoCA ≤22 and/or SDMT ≤13 (for those educated ≤6 years) or SDMT ≤32 (for those educated \>6 years)
  • Meet criteria for Mild Cognitive Impairment based on the Vascular Dementia Battery (for caregivers):
  • At least 21 years old
  • Ability to provide informed consent
  • Consent to recording / photo-taking
  • Staying with or having knowledge of the stroke survivor's functioning
  • No major psychiatric illnesses
  • Able to understand and converse in English
What rules you out
  • (for stroke survivors):
  • Less than 21 years old
  • More than 65 years old
  • Unable to provide informed consent
  • Refuse recording
  • Not living in the community and having less than three months after stroke
  • Significant aphasia or physical disability issues which will impede them from performing cognitive tasks in the interventions and assessments
  • Major psychiatric illnesses
  • Not able to understand and converse in English Exclusion Criteria (for caregivers):
  • Less than 21 years old
  • Unable to provide informed consent
  • Refuse recording
  • Not staying with or not having knowledge of the stroke survivor's functioning
  • Major psychiatric illnesses
  • Not able to understand and converse in English

The study team makes the final eligibility decision.

Where it's taking place

  • Singapore, Singapore

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.